Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity

References

• Nielsen PE, Engholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991; 254(5037):1497-500; PMID:1962210; http://dx.doi.org/10.1126/science.1962210
   PubMed Web of Science ®Google Scholar
• Engholm M, Buchardt O, Nielsen PE, Berg RH. Peptide nucleic acids (PNA). Oligonucleotide analogues with an achiral peptide backbone. J Amer Chem Soc 1992; 114:1895-7; http://dx.doi.org/10.1021/ja00031a062
   Web of Science ®Google Scholar
• Nielsen PE, Egholm M, Berg RH, Buchardt O. Peptide nucleic acids (PNA). DNA analogues with a polyamide backbone. Antisense Research and Application. Crook S, Lebleu B. (eds.). CRC Press, Boca Raton, 1993; 363-373
   Google Scholar
• Egholm M, Buchardt O, Nielsen PE, Berg RH. Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA). J Amer Chem Soc 1992; 114:9677-8; http://dx.doi.org/10.1021/ja00050a068
   Web of Science ®Google Scholar
• Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, Driver DA, Berg RH, Kim SK, Norden B, Nielsen PE. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 1993; 365:566-8; PMID:7692304; http://dx.doi.org/10.1038/365566a0
   PubMed Web of Science ®Google Scholar
• Wittung P, Nielsen PE, Buchardt, O, Egholm, M, Norden B. DNA like double helix formed by peptide nucleic acid. Nature 1994; 368:561-3; PMID:8139692; http://dx.doi.org/10.1038/368561a0
   PubMed Web of Science ®Google Scholar
• Nielsen PE. Peptide nucleic acids-protocol and applications. Norfolk: Horizon Bioscience; 2014
   Google Scholar
• Lohse J, Dahl O, Nielsen PE. Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc Natl Acad Sci USA 1999; 96(21):11804-08; PMID:10518531; http://dx.doi.org/10.1073/pnas.96.21.11804
   PubMed Web of Science ®Google Scholar
• Tomac S, Sarkar M, Ratilainen T, Wittung P, Nielsen PE, Nordén B, Gräslund A. Ion effect on the stability and conformation of peptide nucleic acid complexes. J Am Chem Soc 1996; 118:5544-52; http://dx.doi.org/10.1021/ja960495l
   Web of Science ®Google Scholar
• Demidov VV, Potaman VN, Kamenetskii MDF, Egholm M, Buchart O, Sonnischsen SH, Nielsen P E. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 1994; 48:1310-3; PMID:7945427; http://dx.doi.org/10.1016/0006-2952(94)90171-6
   PubMed Web of Science ®Google Scholar
• Eriksson M, Christensen L, Schmidt J, Haaima G, Orgel L, Nielsen PE. Sequence dependent N-terminal rearrangement and degradation of peptide nucleic acid (PNA) in aqueous solution. New J Chem 1998; 22:1055-9; http://dx.doi.org/10.1039/a803214i
   Web of Science ®Google Scholar
• Ray A, Norden B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. Faseb J 2000; 14, 1041-60; PMID:10834926
   PubMed Web of Science ®Google Scholar
• Lundin K E, Good L, Stomberg R, Graslund A, Smith CIE. Biological activity and biotechnological aspects of peptide nucleic acid. Adv Genet 2006; 16:1-51; http://dx.doi.org/10.1016/S0065-2660(06)56001-8
   Web of Science ®Google Scholar
• Fabani MM, Gait M J. miR-122 targeting with LNA-2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 2008; 14:336-46; PMID:18073344; http://dx.doi.org/10.1261/rna.844108
   PubMed Web of Science ®Google Scholar
• Zhang N, Appella H. Advantages of Peptide Nucleic Acids as diagnostic platform for the detection of nucleic acids in resource limited settings. J Infect Dis 2010; 201:S42-S45; PMID:20225945; http://dx.doi.org/10.1086/650389
   PubMed Web of Science ®Google Scholar
• Briones C, Moreno M. Applications of peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) in biosensor development. Anal Bioanal Chem 2012; 402:3071-89; PMID:22297860; http://dx.doi.org/10.1007/s00216-012-5742-z
   PubMed Web of Science ®Google Scholar
• Pensato S, Saviano M, Romanelli A. New peptide nucleic acid analogues: synthesis and applications. Expert Opin Biol Ther 2007; 7(8):1219-32; PMID:17696820; http://dx.doi.org/10.1517/14712598.7.8.1219
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11(9):597-610; PMID:20661255
   PubMed Web of Science ®Google Scholar
• He L, Hannon G J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2010; 5(7):522-31; http://dx.doi.org/10.1038/nrg1379
   Web of Science ®Google Scholar
• Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human diseases. Development 2005; 132:4643-62; http://dx.doi.org/10.1242/dev.02073
   Web of Science ®Google Scholar
• Brown B D, Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental application. Nat Rev Genet 2009; 10:578-85; PMID:19609263; http://dx.doi.org/10.1038/nrg2628
   PubMed Web of Science ®Google Scholar
• Kota SK, Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discov Today 2010; 15:733-40; PMID:20692360; http://dx.doi.org/10.1016/j.drudis.2010.07.003
   PubMed Web of Science ®Google Scholar
• Hennessy EJ, Moore KJ. Using microRNA as an alternative treatment for hyperlipidemia and Cardiovascular Disease: cardio-miRs in the pipeline. Cardiovasc Pharmacol 2013; 62(3):247-54; http://dx.doi.org/10.1097/FJC.0b013e31829d48bf
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Carlo M, Croce CM. Targeting MicroRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010 9(10):775-89; PMID:20885409; http://dx.doi.org/10.1038/nrd3179
   PubMed Web of Science ®Google Scholar
• Dias N; Stein C A. Antisense Oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 2002; 1(5):347-55; PMID:12489851
   PubMed Web of Science ®Google Scholar
• Havens MA, Duelli DM, Hastings ML. Targeting RNA Splicing for Disease Therapy. Wiley Interdiscip Rev RNA. 2013; 4(3):247-66; PMID:23512601; http://dx.doi.org/10.1002/wrna.1158
   PubMed Web of Science ®Google Scholar
• Douglas AGL, Wood MJW. RNA splicing: disease and therapy. Brif Funct Genomics 2011; 10(3):51-164
   PubMed Web of Science ®Google Scholar
• Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single basepair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90(1-2)41-54; PMID:1427786; http://dx.doi.org/10.1007/BF00210743
   PubMed Web of Science ®Google Scholar
• Ars E, Serra E, García J, Kruyer H, Gaona A, Lazaro C, Estivill X. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000; 9(2):237-47; PMID:10607834; http://dx.doi.org/10.1093/hmg/9.2.237
   PubMed Web of Science ®Google Scholar
• Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengut S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P. Splicing defects in the ataxiatelangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet. 1999; 64(6):1617-31; PMID:10330348; http://dx.doi.org/10.1086/302418
   PubMed Web of Science ®Google Scholar
• Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303:5654:95-8; PMID:14631048; http://dx.doi.org/10.1126/science.1090599
   PubMed Web of Science ®Google Scholar
• Soifer HS, Rossi JJ, Saetrom P, MicroRNAs in disease and potential therapeutic application. Mol Ther 2007; 15(12):2070-1079; PMID:17878899; http://dx.doi.org/10.1038/sj.mt.6300311
   PubMed Web of Science ®Google Scholar
• Lennox KA, Behlke MA. Chemical modification and design of anti-miRNA oligonucleotides. Gene Therapy, 2011; 18:1111-20; PMID:21753793; http://dx.doi.org/10.1038/gt.2011.100
   PubMed Web of Science ®Google Scholar
• Lebedeva I, Stein CA. Antisense oligonucleotides:promise and reality. Annu Rev Pharmacol Toxicol 2001; 41:403-19; PMID:11264463; http://dx.doi.org/10.1146/annurev.pharmtox.41.1.403
   PubMed Web of Science ®Google Scholar
• Rayburn ER, Zhang R. Antisense, RNAi and gene silencing strategies for therapy: mission possible or impossible?. Drug Discov Today 2008; 13(11-12):513-21; PMID:18549978; http://dx.doi.org/10.1016/j.drudis.2008.03.014
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. Embo Mol Med 2014; 6(7):851-64; PMID:24935956; http://dx.doi.org/10.15252/emmm.201100899
   PubMed Web of Science ®Google Scholar
• Zhen L, Alhousseynou S, Yang D. MicroRNA: and Emerging Therapeutic target and Intervention Tool. Int J Mol Sci 2008; 9:978-99; PMID:19325841; http://dx.doi.org/10.3390/ijms9060978
   PubMed Web of Science ®Google Scholar
• Esau CC. Inhibition of microRNA with antisense oligonucleotides. Methods 2008; 44:55-60; PMID:18158133; http://dx.doi.org/10.1016/j.ymeth.2007.11.001
   PubMed Web of Science ®Google Scholar
• Lennox KA, Sabel JL, Johnson MJ, Moreira BG, Fletcher CA, Rose SD, Behlke MA, Laikhter AL, Walder JA, Dagle JM. Characterization of modified antisense oligonucleotides in Xenopus laevis embryos. Oligonucleotides 2006; 16(1):26-42; PMID:16584293; http://dx.doi.org/10.1089/oli.2006.16.26
   PubMedGoogle Scholar
• Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 2006; 34:2294-304; PMID:16690972; http://dx.doi.org/10.1093/nar/gkl183
   PubMed Web of Science ®Google Scholar
• Stenvang J, Kauppinen S. MicroRNAs as targets for antisense-based therapeutics. Expert Opin Biol Ther 2008; 8:59-81; PMID:18081537; http://dx.doi.org/10.1517/14712598.8.1.59
   PubMed Web of Science ®Google Scholar
• Lennox KA, Behlke MA. A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res 2010; 27:1788-99; PMID:20424893; http://dx.doi.org/10.1007/s11095-010-0156-0
   PubMed Web of Science ®Google Scholar
• van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012; 11:860-72; PMID:23080337; http://dx.doi.org/10.1038/nrd3864
   PubMed Web of Science ®Google Scholar
• Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S Inhibition of microRNA function by antimiR oligonucleotides. Silence 2012; 3(1):1; PMID:22230293; http://dx.doi.org/10.1186/1758-907X-3-1
   PubMedGoogle Scholar
• Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008b; 452:896-9; http://dx.doi.org/10.1038/nature06783
   PubMed Web of Science ®Google Scholar
• Watts JK, Deleavey GF, Damha MJ. Chemically modified siRNA: tools and applications. Drug Discov. Today 2008; 13:842-55
   Google Scholar
• Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004; 10:544-50; PMID:14970398; http://dx.doi.org/10.1261/rna.5235104
   PubMed Web of Science ®Google Scholar
• Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. PLoS Biol 2004; 2:E98; PMID:15024405; http://dx.doi.org/10.1371/journal.pbio.0020098
   PubMed Web of Science ®Google Scholar
• Pallan PS, Greene EM, Jicman PA, Pandey RK, Manoharan M, Rozners E, Egli M. Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA. Nucleic Acids Res. 2011; 39(8) 3482-95; PMID:21183463; http://dx.doi.org/10.1093/nar/gkq1270
   PubMed Web of Science ®Google Scholar
• Petersen M, Wengel J. LNA: a versatile tool to therapeutics and genomics. Trends Biotechnol. 2003; 21(2):74-81; PMID:12573856; http://dx.doi.org/10.1016/S0167-7799(02)00038-0
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029-33; PMID:16024602; http://dx.doi.org/10.1158/0008-5472.CAN-05-0137
   PubMed Web of Science ®Google Scholar
• Obad S, Dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C; Fu C, Lindow M, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011; 43:371-8; PMID:21423181; http://dx.doi.org/10.1038/ng.786
   PubMed Web of Science ®Google Scholar
• Swayze EE, Siwkowski AM, Wancewicz EV, Migawa MT, Wyzykiewicz TK, Hung G, Monia BP. Bennett CF. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 2007; 35; 687-700; PMID:17182632; http://dx.doi.org/10.1093/nar/gkl1071
   PubMed Web of Science ®Google Scholar
• Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L, Patton JG. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 2007; 39:259-63; PMID:17220889; http://dx.doi.org/10.1038/ng1953
   PubMed Web of Science ®Google Scholar
• Oh SY, Ju YS, Park H. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. Mol Cells 2009; 28:341-5; PMID:19812898; http://dx.doi.org/10.1007/s10059-009-0134-8
   PubMed Web of Science ®Google Scholar
• Fabani MM, Abreu-Goodger, C, Williams D, Lyons PA, Torres AG, Smith KG, Enright AJ, Gait MJ, Vigorito E. Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 2010; 38(13):4466-75; PMID:20223773; http://dx.doi.org/10.1093/nar/gkq160
   PubMed Web of Science ®Google Scholar
• Cheng CJ, Saltzman WM. Polymer nanoparticle–mediated delivery of microRNA inhibition and alternative splicing. Mol Pharm 2012; 9(5):1481-8; PMID:22482958
   PubMed Web of Science ®Google Scholar
• Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 2012; 109(26):E1695-704; http://dx.doi.org/10.1073/pnas.1201516109
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG; Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005; 438:685-9; PMID:16258535; http://dx.doi.org/10.1038/nature04303
   PubMed Web of Science ®Google Scholar
• Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28(4):341-7; PMID:20351690; http://dx.doi.org/10.1038/nbt.1618
   PubMed Web of Science ®Google Scholar
• Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V, Giacomini P, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 21; 3(5):e2236; http://dx.doi.org/10.1371/journal.pone.0002236
   Google Scholar
• Fabbri E, Manicardi A, Tedeschi T, Sforza S, Bianchi N, Brognara E, Finotti, A, Breveglieri G, Borgatti M, Corradini R, et al. Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs). Chem Med Chem 2011; 6(12):2192-202; PMID:22012891; http://dx.doi.org/10.1002/cmdc.201100270
   PubMed Web of Science ®Google Scholar
• Brognara E, Fabbri E, Aimi F, Manicardi A, Bianchi N, Finotti A, Breveglieri G, Borgatti M, Corradini R, Marchelli R, et al. Peptide nucleic acid targeting miR-221 modulate p27kip1 expression in breast cancer MDA-MB-231 cells. Int J of Onc 2012; 41:2119-27
   PubMed Web of Science ®Google Scholar
• Song J, Kim D, Chun CH, Jin EJ. MicroRNA-375, a new regulator of cadherin-7, suppresses the migration of chondrogenic progenitors. Cell Signal. 2013; 25(3):698-706; PMID:23178988; http://dx.doi.org/10.1016/j.cellsig.2012.11.014
   PubMed Web of Science ®Google Scholar
• Bonham MA, Brown S, Boyd AL, Brown, PH, Bruckenstein DA, Hanvey JC, Thomson SA, Pipe A, Hassman F, Bisi JE, et al. An assessment of the antisense properties of RNaseH competent and steric-blocking oligomers. Nucleic Acids Res 1995; 23:1197-203; PMID:7537874; http://dx.doi.org/10.1093/nar/23.7.1197
   PubMed Web of Science ®Google Scholar
• Shiraishi T, Hamzavi R, Nielsen PE. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells. Nucleic Acids Res 2008; 36:4424-32; PMID:18596083; http://dx.doi.org/10.1093/nar/gkn401
   PubMed Web of Science ®Google Scholar
• Adlerz L, Soomets U, Holmlund L, Viirlaid S, Langel U Iverfeldt, K. Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes. Neurosci Lett 2003; 336:55-9; PMID:12493601; http://dx.doi.org/10.1016/S0304-3940(02)01219-3
   PubMed Web of Science ®Google Scholar
• Pession A, Tonelli R, Fronza R, Sciamanna E, Corradini R, Sforza S, Tedeschi T, Marchelli, R, Montanaro L, Camerin C, et al. Targeted inhibition of NMYC by peptide nucleic acid (PNA) in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Int J Oncol 2004; 24:265-72; PMID:14719101
   PubMed Web of Science ®Google Scholar
• Bendifallah N, Rasmussen FW, Zachar V, Ebbesen P, Nielsen PE, Koppelhus U. Evaluation of cell-penetrating peptides (cpps) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconj Chem 2006; 17:750-8; http://dx.doi.org/10.1021/bc050283q
   PubMed Web of Science ®Google Scholar
• Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998; 16:857-61; PMID:9743120; http://dx.doi.org/10.1038/nbt0998-857
   PubMed Web of Science ®Google Scholar
• Rothbard JB, Jessop TC, Lewis RS, Murray B A, Wender PA. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc 2004; 126:9506-8; PMID:15291531; http://dx.doi.org/10.1021/ja0482536
   PubMed Web of Science ®Google Scholar
• Abes R, Arzumanov A, Moulton H, Abes S, Ivanova G, Gait MJ, Iversen P, Lebleu B. Arginine-rich cell penetrating peptides: Design, structure-activity, and applications to alter premRNA splicing by steric-block oligonucleotides. J Pept Sci 2008; 14:455-60; PMID:18236382; http://dx.doi.org/10.1002/psc.979
   PubMed Web of Science ®Google Scholar
• Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjugate Chem 2008; 19:1526-34; http://dx.doi.org/10.1021/bc800068h
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Johansson HJ, Holm T, Langel Ü. A Novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Ther 2007; 15:1820-6; PMID:17622242; http://dx.doi.org/10.1038/sj.mt.6300255
   PubMed Web of Science ®Google Scholar
• Braun K, Peschke P, Pipkorn R, Lampel S, Wachsmth M, Waldeck W, Friendrick E, Debus JA. Biological transporter for the delivery of peptide ncleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol 2002; 318:237-43; PMID:12051833; http://dx.doi.org/10.1016/S0022-2836(02)00031-1
   PubMed Web of Science ®Google Scholar
• Ivanova G D, Arzumanov A, Abes R, Yin H, Wood MJA, Lebleu B, Gait MJ. Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res 2008; 36:6418-28; PMID:18842625; http://dx.doi.org/10.1093/nar/gkn671
   PubMed Web of Science ®Google Scholar
• Ganesh KN, Nielsen PE. Peptide Nucleic Acids: analogs and derivatives. Curr Org Chem 2000; 4:931-43; http://dx.doi.org/10.2174/1385272003375969
   Web of Science ®Google Scholar
• Nielsen PE, Haaima G. Peptide Nucleic acid (PNA). A DNA mimic with a pseudopeptide backbone. Chem Soc Rev 1997; 26:73-8; http://dx.doi.org/10.1039/cs9972600073
   Web of Science ®Google Scholar
• Corradini R, Sforza S, Tedeschi T, ToTsingan F, Manicardi A, Marchelli R. Peptide nucleic acids with a structural biased backbone. Updated review and emerging challenges. Curr Top Med 2011; 11:1535-54; http://dx.doi.org/10.2174/156802611795860979
   PubMed Web of Science ®Google Scholar
• Kumar VA, Ganesh K. Conformationally constrained PNA analogues: Structural evolution toward DNA/RNA binding selectivity. Acc Chem Res 2005; 38:404-12; PMID:15895978; http://dx.doi.org/10.1021/ar030277e
   PubMed Web of Science ®Google Scholar
• Corradini R, Sforza S, Tedeschi T, Totsingan F, Manicardi A, Marchelli R. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges. Curr Top Med Chem 2011; 11:1535-54; PMID:21510833; http://dx.doi.org/10.2174/156802611795860979
   PubMed Web of Science ®Google Scholar
• Tedeschi T, Sforza S, Dossena A, Corradini R, Marchelli R. Lysine-based peptide nucleic acids (PNAs) with strong chiral constraint: control of helix handedness and DNA binding by chirality. Chirality 2005; 17:S196-204; PMID:15952136; http://dx.doi.org/10.1002/chir.20128
   PubMedGoogle Scholar
• Sforza S, Corradini R, Ghirardi S, Dossena A, Marchelli R. DNA binding of a D-lysine-based chiral PNA: direction control and mismatch recognition. Eur J Org Chem 2000; 16:2905-13; http://dx.doi.org/10.1002/1099-0690(200008)2000:16<2905::AID-EJOC2905>3.0.CO;2-D
   Google Scholar
• Duelholm KL, Petersen KH, Jensen DK, Egholm M, Nielsen PE, Buchardt O. Peptide Nucleic acid (PNA) with a chiral backbone based on alanine. Bioorg Med Chem Lett 1994; 4:1077-80; http://dx.doi.org/10.1016/S0960-894X(01)80684-3
   Web of Science ®Google Scholar
• Katritzky AR, Narindoshvili T. Chiral peptide nucleic acid monomers (PNAM) with modified backbones. Org Biomol Chem 2008; 6:3171-6; PMID:18698477; http://dx.doi.org/; http://dx.doi.org/10.1039/b806141f
   PubMed Web of Science ®Google Scholar
• Menchise V, De Simone G, Tedeschi T, Corradini R, Sforza S, Marchelli R, Capasso D, Saviano M, Pedone C. Insights into peptide nucleic acid (PNA) structural features: the crystal structure of a D-lysine-based chiral PNA-DNA duplex. Proc Natl Acad Sci USA 2003; 100(21):12021-6; PMID:14512516; http://dx.doi.org/10.1073/pnas.2034746100
   PubMed Web of Science ®Google Scholar
• Tedeschi T, Chiari M, Galaverna G, Sforza S, Cretich M, Corradini R, Marchelli R. Detection of the R553X DNA single point mutation related to cystic fibrosis by a “chiral box” D-lysine-peptide nucleic acid probe by capillary electrophoresis. Electrophoresis 2005; 26(22):4310-6; PMID:16287174; http://dx.doi.org/10.1002/elps.200410390
   PubMed Web of Science ®Google Scholar
• Corradini R., Feriotto G, Sforza S, Marchelli R, Gambari R. Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor. J Mol Recognit 2004; 17(1):76-84; PMID:14872540; http://dx.doi.org/10.1002/jmr.646
   PubMed Web of Science ®Google Scholar
• Dose C, Seitz O. Single nucleotide specific detection of DNA by native chemical ligation of fluorescence labeled PNA-probes. Bioorg Med Chem 2008; 16:65-77; PMID:17499998; http://dx.doi.org/10.1016/j.bmc.2007.04.059
   PubMed Web of Science ®Google Scholar
• Zhou P, Dragulescu-Andrasi A, Bhattacharya B, O’Keefe H, Vatta P, Hyldig-Nielsen JJ, Ly DH. Synthesis of cell-permeable peptide nucleic acids and characterization of their hybridization and uptake properties. Bioorg Med Chem Lett 2006; 16:4931-5; PMID:16809033; http://dx.doi.org/10.1016/j.bmcl.2006.06.052
   PubMed Web of Science ®Google Scholar
• Dragulescu-Andrasi A, Rapireddy S, He G, Bhattacharya B, Hyldig-Nielsen JJ, Zon G, Ly DH. Cell-permeable peptide nucleic acid designed to bind to the 5'-untranslated region of E-cadherin transcript induces potent and sequence-specific antisense effects. J Am Chem Soc 2006; 128:16104-12; PMID:17165763; http://dx.doi.org/10.1021/ja063383v
   PubMed Web of Science ®Google Scholar
• Rossi, S, Calabretta A, Tedeschi T, Sforza S, Arcioni S, Baldoni L, Corradini R, Marchelli R. Selective recognition of DNA from olive leaves and olive oil by PNA and modified-PNA microarrays. Artificial DNA:PNA XNA 2012; 3:63-72; http://dx.doi.org/10.4161/adna.20603
   PubMedGoogle Scholar
• Püschl A, Sforza S, Haaima G, Dahl O, Nielsen PE. Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Lett 1998; 39:4707-10; http://dx.doi.org/10.1016/S0040-4039(98)00862-4
   Web of Science ®Google Scholar
• Hamzavi R, Dolle F, Tavitian B, Dahl O, Nielsen PE. Modulation of the pharmacokinetic properties of PNA: Preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconjug Chem 2003; 14:941-54; PMID:13129397; http://dx.doi.org/10.1021/bc034022x
   PubMed Web of Science ®Google Scholar
• Hamzavi R, Meyer C, Metzler-Nolte N. Synthesis of a C-linked glycosylated thymine-based PNA monomer and its incorporation into a PNA oligomer. Org Biomol Chem 2005; 4:3648-51; http://dx.doi.org/10.1039/b607463d
   Web of Science ®Google Scholar
• Dilek I, Madrid M, Singh R, Urrea CP, Armitage BA. Effect of PNA backbone modifications on cyanine dye binding to PNA-DNA duplexes investigated by optical spectroscopy and molecular dynamics simulations. J Am Chem Soc2005; 127:3339-45; PMID:15755150; http://dx.doi.org/10.1021/ja045145a
   PubMed Web of Science ®Google Scholar
• Gupta P, Muse O, Rozners E, Recognition of Double-Stranded RNA by Guanidine-Modified Peptide Nucleic Acids, Biochemistry 2012; 51:63-73; PMID:22146072; http://dx.doi.org/10.1021/bi201570a
   PubMed Web of Science ®Google Scholar
• Pokorski JK, Myers MC, Appella DH. Cyclopropane PNA: Observable triplex melting in a PNA constrained with a 3-membered ring. Tetrahedron Lett 2005; 46:915-7; http://dx.doi.org/10.1016/j.tetlet.2004.12.061
   Web of Science ®Google Scholar
• Myers MC, Witschi MA, Larionova NV, Frank JM, Haynes RD, Hara T, Grajkowski A, Appella DH. A cyclopentane conformational restraint for a peptide nucleic acid: Design, asymmetric synthesis, and improved binding affinity to DNA and RNA. Org Lett 2003; 5:2695-8; PMID:12868892; http://dx.doi.org/10.1021/ol0348811
   PubMed Web of Science ®Google Scholar
• Pokorski JK, Witschi MA, Purnell BL, Appella DH. (S,S)-trans-Cyclopentane-constrained peptide nucleic acids. A general backbone modification that improves binding affinity and sequence specificity. J Am Chem Soc 2004; 126:15067-73; PMID:15548003; http://dx.doi.org/10.1021/ja046280q
   PubMed Web of Science ®Google Scholar
• Govindaraju T, Kumar VA, Ganesh KN. cis-Cyclopentyl PNA (cpPNA) as constrained chiral PNA analogues: Stereochemical dependence of DNA/RNA hybridiation. Chem Commun 2004; 860-1; http://dx.doi.org/10.1039/b317000d
   PubMed Web of Science ®Google Scholar
• Govindaraju T, Kumar VA, Ganesh KN. (1S,2R/1R,2S)-cis-cyclopentyl PNAs (cpPNAs) as constrained PNA analogues: synthesis and evaluation of aeg-cpPNA chimera and stereopreferences in hybridization with DNA/RNA. J Org Chem 2004; 69:5725-34; PMID:15307746; http://dx.doi.org/10.1021/jo049442+
   PubMed Web of Science ®Google Scholar
• Lagriffoule P, Wittung P, Ericksson M, Jensen DK, Norden B, Buchardt O, Nielsen PE. Peptide nucleic acids with a conformationally constrained chiral cyclohexyl-derived backbone. Chem Eur J 1997; 3:912-9; http://dx.doi.org/10.1002/chem.19970030613
   Web of Science ®Google Scholar
• Govindaraju T, Gonnade RG, Bhadbhade MM, Kumar VA, Ganesh KN. (1S,2R/1R,2S)-Aminocyclohexyl Glycyl Thymine PNA:  Synthesis, Monomer Crystal Structures, and DNA/RNA Hybridization Studies. Org Lett 2003; 5:3013-6; PMID:12916969; http://dx.doi.org/10.1021/ol034933m
   PubMed Web of Science ®Google Scholar
• Govindaraju T, Kumar VA, Ganesh KN. Synthesis and Evaluation of (1S,2R/1R,2S)-Aminocyclohexylglycyl PNAs as Conformationally Preorganized PNA Analogues for DNA/RNA Recognition. J Org Chem 2004; 69:1858-65; PMID:15058930; http://dx.doi.org/10.1021/jo035747x
   PubMed Web of Science ®Google Scholar
• Govindaraju T, Kumar VA, Ganesh KN. (SR/RS)-Cyclohexanyl PNAs: Conformationally Preorganized PNA Analogues with unprecedented preference for duplex formation with RNA. J Am Chem Soc, 2005; 127(12):4144-5; PMID:15783176; http://dx.doi.org/10.1021/ja044142v
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Imamura Y, Demizu Y, Kurihara M, Takano M, Kittaka A. β-PNA: peptide nucleic acid (PNA) with a chiral center at the β-position of the PNA backbone. Biorg Med Chem Lett 2011; 21:7317-20; http://dx.doi.org/10.1016/j.bmcl.2011.10.017
   PubMed Web of Science ®Google Scholar
• Kosynkina L, Wang W, Liang TC. A convenient synthesis of chiral Peptide Nucleic Acid (PNA) monomers. Tetrahedron Lett 1994; 35(29):5173-6; http://dx.doi.org/10.1016/S0040-4039(00)77056-0
   Web of Science ®Google Scholar
• Englund EA, Appella DH. γ -Substituted peptide nucleic acids constructed from L-lysine are a versatile scaffold for multifunctional display. Angew Chem Int Ed 2007; 46:1414-141; http://dx.doi.org/10.1002/anie.200603483
   PubMed Web of Science ®Google Scholar
• Englund EA, Appella DH. Synthesis of γ-substituted peptide nucleic acids: A new place to attach fluorophores without affecting DNA binding. Org Lett 2005; 7:3465-7; PMID:16048318; http://dx.doi.org/10.1021/ol051143z
   PubMed Web of Science ®Google Scholar
• De Koning, MC, Petersen L, Weterings JJ, Overhand M, Van der Marel GA, Filippov DV. Synthesis of thiol-modified peptide nucleic acids designed for post-assembly conjugation reactions. Tetrahedron 2006; 62:3248-58; http://dx.doi.org/10.1016/j.tet.2006.01.065
   Web of Science ®Google Scholar
• Dose C, Seitz O. Convergent Synthesis of Peptide Nucleic Acids by Native Chemical Ligation. Org Lett 2005; 7:4365-8; PMID:16178534; http://dx.doi.org/10.1021/ol051489+
   PubMed Web of Science ®Google Scholar
• Pensato S, Saviano M, Bianchi N, Borgatti M, Fabbri E, Gambari R, Romanelli A. A γ-hydroxymethyl PNAs: Synthesis, interaction with DNA and inhibition of protein/DNA interaction. Bioorg Chem 2010; 38:196-201; PMID:20643471; http://dx.doi.org/10.1016/j.bioorg.2010.06.002
   PubMed Web of Science ®Google Scholar
• Avitabile C, Moggio L, Malgieri G, Capasso D, Gaetano S.D, Saviano M, Pedone C, Romanelli A. γ-sulphate PNA (PNA S): Highly selective DNA binding molecule showing promising antigene activity. PLoS One 2012; 7(5):e35774; PMID:22586450; http://dx.doi.org/10.1371/journal.pone.0035774
   PubMedGoogle Scholar
• Sforza S, Tedeschi T, Corradini R, Marchelli R. Induction of helical handedness and DNA binding properties of peptide nucleic acids (PNAs) with two stereogenic centres. Eur J Org Chem 2007; 5879-85; http://dx.doi.org/10.1002/ejoc.200700644
   Web of Science ®Google Scholar
• Dragulescu-Andrasi A, Rapireddy S, Frezza BM, Gayathri C, Gil RR, Ly DH. A simple γ-backbone modification preorganizes peptide nucleic acid into a helical structure. J Am Chem Soc 2006; 128:10258-67; PMID:16881656; http://dx.doi.org/10.1021/ja0625576
   PubMed Web of Science ®Google Scholar
• Crawford MJ, Rapireddy S, Bahal R, Sacui I, Ly DH. Effect of steric constraint at the γ-backbone position on the conformations and hybridization properties of PNAs. J Nucleic Acids 2011; 2011:652702; PMID:21776375; http://dx.doi.org/10.4061/2011/652702
   PubMedGoogle Scholar
• Chenna V, Rapireddy S, Sahu B, Ausin C, Pedroso E, Ly DH. A simple cytosine to G-clamp nucleobase substitution enables chiral γ -PNAs to invade mixed-sequence double-helical B-form DNA. ChemBioChem 2008; 9:2388-91; PMID:18816545; http://dx.doi.org/10.1002/cbic.200800441
   PubMed Web of Science ®Google Scholar
• Rapireddy S, He G, Roy S, Armitage BA, Ly DH. Strand invasion of mixed-sequence B-DNA by acridine-linked, γ-peptide nucleic acid (γ-PNA). J Am Chem Soc 2007; 129:15596-600; PMID:18027941; http://dx.doi.org/10.1021/ja074886j
   PubMed Web of Science ®Google Scholar
• Bahal R, Sahu B, Rapireddy S, Lee CM, Ly DH. Sequence-unrestricted, Watson–Crick recognition of double helical B-DNA by (R)-MiniPEG-γPNAs. ChemBioChem 2012; 13:56-60; PMID:22135012; http://dx.doi.org/10.1002/cbic.201100646
   PubMed Web of Science ®Google Scholar
• Sahu B, Chenna V, KL Lathrop, Thomas SM, Zon G, Livak KJ, Ly DH. Synthesis of Conformationally Preorganized and Cell-Permeable Guanidine-Based γ-Peptide Nucleic Acids (γGPNAs). J Org Chem 2009; 74(4):1509-16; PMID:19161276; http://dx.doi.org/10.1021/jo802211n
   PubMed Web of Science ®Google Scholar
• Sforza S, Tedeschi T, Calabretta A, Corradini R, Camerin C, Tonelli R, Pession A, Marchelli R. A peptide nucleic acid embedding a pseudopeptide nuclear localization sequence in the backbone behaves as a peptide mimic. Eur J Org Chem 2010; 2010:2441-44; http://dx.doi.org/10.1002/ejoc.201000123
   Web of Science ®Google Scholar
• Manicardi A, Fabbri E, Tedeschi T, Sforza S, Bianchi N, Brognara E, Gambari R, Marchelli R, Corradini R. Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells. ChemBioChem 2012; 13:1327-37; PMID:22639449; http://dx.doi.org/10.1002/cbic.201100745
   PubMed Web of Science ®Google Scholar